Literature DB >> 16670632

Issues of concern regarding the use of hypertonic/hyperoncotic fluid resuscitation of hemorrhagic hypotension.

Michael A Dubick1, Stephen P Bruttig, Charles E Wade.   

Abstract

Small volume resuscitation fluids continue to be of interest to the military and limited volume resuscitation is becoming more common in the treatment of hemorrhage in the civilian community. With renewed interest to undertake a large US-Canada multi-center clinical trial of hypertonic saline alone or combined with dextran (HSD) possibly in 2006, concerns related to the safe use of this product continue to surface. This review addresses the use of these products in uncontrolled hemorrhage models, in dehydration and addresses perceived risks associated with hypernatremia, dextran-associated anaphylactoid reactions and effects on coagulation and renal function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670632     DOI: 10.1097/01.shk.0000209525.50990.28

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  13 in total

1.  Resuscitation of traumatic hemorrhagic shock patients with hypertonic saline-without dextran-inhibits neutrophil and endothelial cell activation.

Authors:  Wolfgang G Junger; Shawn G Rhind; Sandro B Rizoli; Joseph Cuschieri; Maria Y Shiu; Andrew J Baker; Linglin Li; Pang N Shek; David B Hoyt; Eileen M Bulger
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

2.  Osmotic stress blocks NF-kappaB-dependent inflammatory responses by inhibiting ubiquitination of IkappaB.

Authors:  Wei-Chun HuangFu; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  FEBS Lett       Date:  2007-11-13       Impact factor: 4.124

3.  Anesthetic management of a horse with traumatic pneumothorax.

Authors:  Maud-Aline Chesnel; Francesco Aprea; R Eddie Clutton
Journal:  Can Vet J       Date:  2012-06       Impact factor: 1.008

4.  Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial.

Authors:  Eileen M Bulger; Susanne May; Jeffery D Kerby; Scott Emerson; Ian G Stiell; Martin A Schreiber; Karen J Brasel; Samuel A Tisherman; Raul Coimbra; Sandro Rizoli; Joseph P Minei; J Steven Hata; George Sopko; David C Evans; David B Hoyt
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

5.  [The concept of small volume resuscitation for preclinical trauma management. Experiences in the Air Rescue Service].

Authors:  M Helm; J Hauke; J Kohler; L Lampl
Journal:  Unfallchirurg       Date:  2013-04       Impact factor: 1.000

6.  Collider bias in trauma comparative effectiveness research: the stratification blues for systematic reviews.

Authors:  Deborah J Del Junco; Eileen M Bulger; Erin E Fox; John B Holcomb; Karen J Brasel; David B Hoyt; James J Grady; Sarah Duran; Patricia Klotz; Michael A Dubick; Charles E Wade
Journal:  Injury       Date:  2015-01-31       Impact factor: 2.586

7.  Hypertonic saline attenuates cord swelling and edema in experimental spinal cord injury: a study utilizing magnetic resonance imaging.

Authors:  Yvette S Nout; Georgeta Mihai; C Amy Tovar; Petra Schmalbrock; Jacqueline C Bresnahan; Michael S Beattie
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598

8.  Life or death? A physiogenomic approach to understand individual variation in responses to hemorrhagic shock.

Authors:  Harold G Klemcke; Bina Joe; Rajiv Rose; Kathy L Ryan
Journal:  Curr Genomics       Date:  2011-09       Impact factor: 2.236

9.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

Review 10.  ROC trials update on prehospital hypertonic saline resuscitation in the aftermath of the US-Canadian trials.

Authors:  Michael A Dubick; Pang Shek; Charles E Wade
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.